LAS VEGAS, NV, Dec. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com – Axim Geospatial is to provide Maptelligent complete GIS services with ...

SAN DIEGO, CA, May 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an ...

Leading Diagnostic Healthcare Company Signs Contract Manufacturing Agreement in Order to Fulfill Sales of IgE and Lactoferrin DED Diagnostic Assays Until this agreement, the Company has been ...

SAN DIEGO, CA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company ...

The Company's Commercialization Partner Versea Ophthalmic Places Re-stock Order of AXIM's Digital Assay Reader AXIM's commercialization partner Versea Ophthalmics has been ramping up sales of the ...

NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today ...

NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company ...

AXIM Biotechnolgies, Inc. is beginning human dermatological clinical trials for Cannabinoid based solutions for psoriasis and eczema. The trials will be conducted at The Maurits Clinic in The Hague, ...

Sapphire Biotech, a facet of Axim, has partnered with ASU by providing licensing technology to support research that strives to inhibit one of the enzymes that facilitates the spread of cancer in the ...